Lates News
Yuanda Pharmaceutical: The global innovative ophthalmic drug GPN01768 [TP-03, 0.25%] introduced by our group for the treatment of demodex blepharitis recently officially received the drug registration certificate issued by the National Medical Products Administration of the People's Republic of China, and did not receive any supplementary information notice during the drug review process, achieving approval for market launch without any supplementary information.
Latest
19 m ago

